image
Healthcare - Biotechnology - NASDAQ - IL
$ 0.4755
4.69 %
$ 39.8 M
Market Cap
-1.03
P/E
INCOME STATEMENT
4.8 M REVENUE
0.00%
-49.7 M OPERATING INCOME
-70.44%
-60.6 M NET INCOME
-142.93%
EFFICIENCY
Earnings Waterfall BioLineRx Ltd.
image
Revenue 4.8 M
Cost Of Revenue 4.63 M
Gross Profit 174 K
Operating Expenses 43.2 M
Operating Income -49.7 M
Other Expenses 10.9 M
Net Income -60.6 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010
REVENUE
Revenue 4.8 0 0 0 0 0 0 0 0 0 113.2 113.2 63.9 31.9
GROSS PROFIT
Cost Of Revenue 4.6 0.7 0.7 0.9 0.9 0.5 0.5 0.5 0.4 0 0 0 22.6 7.2
Gross Profit 0.2 (0.7) (0.7) (0.9) (0.9) (0.5) (0.5) (0.5) (0.4) 0 113.2 113.2 41.3 24.7
OPERATING INCOME
Operating Expenses 43.2 29.2 24.8 22.9 28.1 25.6 25.2 16.5 16.2 15.9 17.6 21.8 15.4 21.0
Selling, General and Administrative Expenses 31.2 11.5 5.3 4.7 4.6 5.8 5.7 5.3 4.7 5.0 4.9 4.6 4.2 5.4
Research and Development Expenses 12.5 17.6 19.5 18.2 23.4 19.8 19.5 11.2 11.5 10.9 12.7 17.2 11.2 15.5
Operating Income (49.7) (29.2) (24.8) (22.9) (28.1) (25.6) (25.2) (16.5) (16.2) (15.9) (17.6) (21.8) (15.4) 3.7
PRE-TAX INCOME
Interest Income Expense 2.2 2.2 1.0 1.5 1.8 21 K 21 K 14 K 15 K 0.4 20.7 K 26 K 1.1 16.6 K
Total Other Income (10.9) 4.2 (2.3) (7.1) 2.7 2.6 0.9 0.7 1.8 6.2 13.2 K 1.4 1.4 (1.6)
Pre-Tax Income (60.6) (25.0) (27.1) (30.0) (25.4) (23.0) (24.4) (15.8) (14.4) (10.2) (17.6) (20.4) 61.5 2.1
NET INCOME
Tax Provision 1 K (6.1) 1.1 0.9 1.4 (4.5) (0.9) (0.7) (1.8) (5.7) 15.8 K (1.4) (2.2) 1.6
Net Income (60.6) (18.9) (28.1) (30.9) (26.8) (18.5) (24.4) (15.8) (14.4) (10.2) (17.6) (20.4) (13.2) 2.1
EPS 0.94 0.37 0.64 1.84 2.75 2.56 4.06 4.23 4.2 4.71 11.8 18.1 16 2.54